Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schonbach, EM; Strauss, RW; Cattaneo, MEGV; Fujinami, K; Birch, DG; Cideciyan, AV; Sunness, JS; Zrenner, E; Sadda, SR; Scholl, HPN.
Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16
AM J OPHTHALMOL. 2022; 233: 78-89.
Doi: 10.1016/j.ajo.2021.07.013
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Strauß Rupert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- PURPOSE: Stargardt disease type 1 (STGD1) is the most common macular dystrophy. The assessment of fixation describes an important dimension of visual function, but data on its progression over time are limited. We present longitudinal changes and investigate its usefulness for clinical trials. DESIGN: International, multicenter, prospective cohort study. METHODS: Included were 239 individuals with genetically confirmed STGD1 (one or more disease-causing ATP binding cassette subfamily A member 4 [ABCA4] variant). We determined the fixation stability (FS) using 1 SD of the bivariate contour ellipse area (1 SDBCEA) and fixation location (FL) using the eccentricity of fixation from the fovea during five study visits every 6 months. RESULTS: At baseline, 239 patients (105 males [44%]) and 459 eyes, with a median age of 32 years, were included. The baseline mean logBCEA was 0.70 +/- 1.41 log deg2 and the mean FL was 6.25 degrees +/- 4.40 degrees. Although the mean logBCEA did not monotonically increase from visit to visit, the overall yearly increase in the logBCEA was 0.124 log deg(2) (95% CI, 0.063-0.185 log deg(2)). The rate of change was not different between the 2 years but increased faster in eyes without flecks outside of the vascular arcades and depended on baseline logBCEA. FL did not change statistically significantly over time. CONCLUSIONS: Fixation parameters are unlikely to be sensitive outcome measures for clinical trials in STGD1 but may provide useful ancillary information in selected cases to longitudinally describe and understand an eye's visual function. (C) 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC ND license.